SL Therapeutics, Inc. (XKON:258540)

South Korea flag South Korea · Delayed Price · Currency is KRW
600.00
+68.00 (12.78%)
At close: Mar 28, 2025, 3:30 PM KST
-34.43%
Market Cap 3.13B
Revenue n/a
Net Income n/a
Shares Out 5.21M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 9
Average Volume 4,050
Open 600.00
Previous Close 532.00
Day's Range 600.00 - 600.00
52-Week Range 430.00 - 2,260.00
Beta -0.41
RSI 47.45
Earnings Date n/a

About SL Therapeutics

SL Therapeutics, Inc. engages in cell therapy and medical device businesses. The company develops cell therapeutic solutions based on its cell reprogramming technology to treat various diseases with a focus on spinal cord injury, and age and genetically related diseases; and hair follicle cells, skin cells, and cells of the central nervous system. It also manufactures automated magnetic resonance imaging systems; and Supra Elite and Dexino bone mineral density measurement devices. The company was formerly known as StemLab Inc. SL Therapeutics, ... [Read more]

Industry Commercial Physical and Biological Research
Founded 2011
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 258540
Full Company Profile

News

There is no news available yet.